N4 PHARMA PLC — Major Shareholding Notification 2020

Jun 17, 2020

National Storage Mechanism | Additional information

RNS Number : 2354Q

Evgen Pharma PLC

17 June 2020

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Evgen Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	change in percentage of voting rights arising upon a new issue of shares by the issuer
3. Full name of person(s) subject to the notification obligation: iii		Enterprise Ventures Limited
4. Full name of shareholder(s)  (if different from 3.):iv		South Yorkshire Investment Fund Limited
5. Date of the transaction and date on which the threshold is crossed or reached: v		29th May 2020
6. Date on which issuer notified:		16th June 2020
7. Threshold(s) that is/are crossed or reached: vi, vii		3%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction							Resulting situation after the triggering transaction
Number of Shares				Number of Voting Rights			Number of shares			Number of voting rights			% of  voting rights
Direct			Direct xi	Indirecti		Direct		Indirect
GB00BSVYN304	3,772,949				3,772,949			2,777,776			2,777,776	Nil		2.09		Nil
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii			Exercise/ Conversion Period xiv				Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
None
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii			Exercise/ Conversion period xviii		Number of voting rights instrument refers to				% of voting rights xix, xx
None													Nominal		Delta
Total (A+B+C)
Number of voting rights									Percentage of voting rights
2,779,776									2.09%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:	Enterprise Ventures Limited
15. Contact telephone number:	01772 270 570

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLFZGMVRNDGGZG